Related Experiment Video
Updated: Apr 21, 2026
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis
Insights
This revised guideline offers updated recommendations for diagnosing and managing bronchiolitis in infants and young children up to 23 months old. It provides evidence-based guidance for clinical practice.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Bronchiolitis is a common viral respiratory infection in infants.
- Previous clinical practice guidelines for bronchiolitis diagnosis and management were published in 2006.
- There is a need for updated evidence-based recommendations.
Purpose of the Study:
- To revise and update the clinical practice guideline for the diagnosis and management of bronchiolitis.
- To provide evidence-based recommendations for healthcare professionals treating children aged 1-23 months.
- To outline key action statements with levels of evidence and recommendations.
Main Methods:
- Systematic review of the literature.
- Development of key action statements based on evidence.
- Inclusion of benefit-harm analysis and recommendation levels.
Main Results:
- The guideline addresses the diagnosis and management of bronchiolitis.
- Key action statements are provided for clinical decision-making.
- Recommendations are tailored for children aged 1 through 23 months.
Conclusions:
- This revised guideline provides current, evidence-based recommendations for bronchiolitis.
- It aims to improve the diagnosis and management of this common childhood illness.
- Healthcare providers can utilize these updated guidelines for optimal patient care.
Abstract:
This guideline is a revision of the clinical practice guideline, "Diagnosis and Management of Bronchiolitis," published by the American Academy of Pediatrics in 2006. The guideline applies to children from 1 through 23 months of age. Other exclusions are noted. Each key action statement indicates level of evidence, benefit-harm relationship, and level of recommendation. Key action statements are as follows:
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:30Asthma-IV: Nursing Management
First, in...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment